JV sounds good with immediate revenue to GDP. That leaves the Aventis-Bering collaboration results yet to come and expected soonish. At last we are getting some action with GDP. What it needs now is a significant contract (with a royalty stream) to use Gradiflow in industrial scale fractionation - in the near term (the Advantek agreement has as its third stage a production facility in mainland China but its a way off).
